6-mercaptopurine: pharmacokinetics in animals and preliminary results in children.
暂无分享,去创建一个
R. D. De Abreu | C. De Bruyn | E. van der Kleijn | E. Schretlen | T. Schouten | G. De Vaan | M. Oosterbaan
[1] R. D. De Abreu,et al. High-performance liquid chromatographic determination of plasma 6-mercaptopurine in clinically relevant concentrations. , 1982, Journal of chromatography.
[2] J H Goldie,et al. Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.
[3] K. Manning. Improved viscometric assay for cellulase. , 1981, Journal of biochemical and biophysical methods.
[4] Lee Sh,et al. The effects of inhibitors of DNA biosynthesis on the cytotoxicity of 6-thioguanine. , 1981 .
[5] D. Green,et al. COMPARISON OF THREE METHODS OF CENTRAL-NERVOUS-SYSTEM PROPHYLAXIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKÆMIA , 1980, The Lancet.
[6] J. R. Roti Roti,et al. Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity. , 1980, Cancer research.
[7] D. J. Adamson,et al. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. , 1975, Cancer research.
[8] D. Tidd,et al. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. , 1974, Cancer research.
[9] D. Tidd,et al. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine. , 1974, Cancer research.
[10] D. Tidd,et al. A delayed cytotoxic reaction for 6-mercaptopurine. , 1972, Cancer research.